← Leaderboards
Anand Kumar Rohatgi
Ut Southwestern Medical Center
$8,142,204
Attributed
$8,142,204
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,142,204 · 5
By mechanism
R01$6,320,499 · 2
K24$822,271 · 1
K08$664,610 · 1
R38$334,824 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Helen H. Hobbs$30,094,310
- Jay D Horton$17,439,528
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeHigh Density LipoproteinsAtherosclerosisLinkPathway InteractionsAntiatherogenicLipidsProteomicsCohortReverse Cholesterol TransportVariantCholesterolHeartPreventMetabolismEventCause Of DeathCardiovascular Disorder RiskLipid MetabolismTraitReportingCareerMentorsMetabolic
Grant awards (22)
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians$575,981
R01 · FY2025 · HL · contact PI
Mentoring Patient-Oriented Research in Deep Lipid Phenotyping for Cardiovascular Disease$122,720
K24 · FY2025 · HL · contact PI
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians$643,552
R01 · FY2024 · HL · contact PI
University of Texas Southwestern - Stimulating Access to Research in Residency (UT-StARR) Program$334,824
R38 · FY2024 · HL · contact PI
Mentoring Patient-Oriented Research in Deep Lipid Phenotyping for Cardiovascular Disease$122,720
K24 · FY2024 · HL · contact PI
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians$664,926
R01 · FY2023 · HL · contact PI
Mentoring Patient-Oriented Research in Deep Lipid Phenotyping for Cardiovascular Disease$114,256
K24 · FY2023 · HL · contact PI
The Genetic and Molecular Basis of Cholesterol Efflux$696,639
R01 · FY2022 · HL · contact PI
Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians$665,725
R01 · FY2022 · HL · contact PI
Mentoring Patient-Oriented Research in Deep Lipid Phenotyping for Cardiovascular Disease$114,823
K24 · FY2022 · HL · contact PI
The Genetic and Molecular Basis of Cholesterol Efflux$703,119
R01 · FY2021 · HL · contact PI
Mentoring Patient-Oriented Research in Deep Lipid Phenotyping for Cardiovascular Disease$115,377
K24 · FY2021 · HL · contact PI
The Genetic and Molecular Basis of Cholesterol Efflux$733,484
R01 · FY2020 · HL · contact PI
Mentoring Patient-Oriented Research in Deep Lipid Phenotyping for Cardiovascular Disease$115,921
K24 · FY2020 · HL · contact PI
The Genetic and Molecular Basis of Cholesterol Efflux$805,682
R01 · FY2019 · HL · contact PI
Mentoring Patient-Oriented Research in Deep Lipid Phenotyping for Cardiovascular Disease$116,454
K24 · FY2019 · HL · contact PI
The Genetic and Molecular Basis of Cholesterol Efflux$831,391
R01 · FY2018 · HL · contact PI
Moving Beyond HDL Cholesterol, HDL Function as a Coronary Disease Biomarker$155,725
K08 · FY2017 · HL · contact PI
Moving Beyond HDL Cholesterol, HDL Function as a Coronary Disease Biomarker$155,725
K08 · FY2016 · HL · contact PI
Moving Beyond HDL Cholesterol, HDL Function as a Coronary Disease Biomarker$117,720
K08 · FY2015 · HL · contact PI
Moving Beyond HDL Cholesterol, HDL Function as a Coronary Disease Biomarker$117,720
K08 · FY2014 · HL · contact PI
Moving Beyond HDL Cholesterol, HDL Function as a Coronary Disease Biomarker$117,720
K08 · FY2013 · HL · contact PI